Xilio Therapeutics, Inc. Share Price
NASDAQ: XLO | Micro CapXilio Therapeutics, Inc. Stock Performance
Open $9.02 | Prev. Close $9.14 | Circuit Range N/A |
Day Range $9.02 - $9.02 | Year Range $0.47 - $9.75 | Volume 189 |
Average Traded $9.02 |
Xilio Therapeutics, Inc. Share Price Today
As of 29 August 2026, Xilio Therapeutics, Inc.'s share price is $9.14. The stock opened at $9.02, compared to its previous close of $9.14. During today's trading session, Xilio Therapeutics, Inc.'s share price traded between $9.02 and $9.02, with an average price of $9.02. Over the past 52 weeks, the stock has recorded a high of $9.75 and a low of $0.47. In terms of performance, Xilio Therapeutics, Inc.'s share price has risen by 1622.22% over the last six months and is up 1206.43% on a year-on-year basis.
Xilio Therapeutics, Inc. Share Price Chart
Xilio Therapeutics, Inc. Stock Fundamentals & Key Indicators
Market Cap $76.44M | PE Ratio (TTM) -2.18 | Dividend Yield N/A |
EPS (TTM) $-4.19 | Revenue (TTM) $43.77M | Return On Equity (TTM) -165.11% |
Profit Margin -133.07% | Debt to Equity 1.60 | Quarterly Earnings Growth YoY N/A |
Xilio Therapeutics, Inc. Quarterly Profit & Loss
All figures in USD
Xilio Therapeutics, Inc. Annual Profit & Loss
All figures in USD
About Xilio Therapeutics, Inc.
Xilio Therapeutics, Inc., a clinical-stage biotechnology company, engages in the discovery and development of tumor-activated immuno-oncology therapies. The company's checkpoint inhibitor program includes XTX101, an investigational Fc-enhanced, tumor-activated anti-CTLA-4 mAb that is in Phase 2 clinical trial for patients with advanced solid tumors. It also develops cytokine programs, which comprises XTX202, a tumor-activated beta-gamma biased IL-2, currently under Phase 2 clinal trials; and XTX301, an investigational tumor-activated, engineered IL-12 molecule, currently under Phase 1 studies. The company was founded in 2016 and is headquartered in Waltham, Massachusetts.
Xilio Therapeutics, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Aug 2026 | $9.18 | $9.14 | -0.27% |
Jul 2026 | $9.08 | $9.17 | -3.22% |
Jun 2026 | $8.43 | $9.47 | +11.80% |
May 2026 | $8.43 | $8.47 | +6.47% |
Apr 2026 | $8.58 | $7.96 | -6.02% |
Mar 2026 | $0.52 | $8.47 | +1,495.10% |
Feb 2026 | $0.58 | $0.53 | -10.30% |
Jan 2026 | $0.64 | $0.59 | -7.93% |
Dec 2025 | $0.75 | $0.64 | -14.49% |
Nov 2025 | $0.82 | $0.75 | -5.41% |
Oct 2025 | $0.84 | $0.80 | -7.67% |
Sep 2025 | $0.69 | $0.86 | +23.00% |
XLO Share Price FAQs
What is Xilio Therapeutics, Inc. share price today?
What is the 52 week high and 52 week low of Xilio Therapeutics, Inc. stock?
What is XLO's market capitalisation today?
What is the 5 year returns of XLO?
What is the high & low stock price of XLO today?
Can I buy XLO shares in India?